|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49.
2024.PubMed/NCBI
|
|
2
|
Stoop TF, Javed AA, Oba A, Koerkamp BG,
Seufferlein T, Wilmink JW and Besselink MG: Pancreatic cancer.
Lancet. 405:1182–1202. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai J, Chen H, Lu M, Zhang Y, Lu B, You L,
Zhang T, Dai M and Zhao Y: Advances in the epidemiology of
pancreatic cancer: Trends, risk factors, screening, and prognosis.
Cancer Lett. 520:1–11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergman PJ: Cancer immunotherapy. Vet Clin
North Am Small Anim Pract. 54:441–468. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang K, Halima A and Chan TA: Antigen
presentation in cancer-mechanisms and clinical implications for
immunotherapy. Nat Rev Clin Oncol. 20:604–623. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bednar F and Pasca di Magliano M:
Context-dependent immune responses explain pancreatic cancer
immunoresistance. Cancer Cell. 37:261–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farhangnia P, Khorramdelazad H, Nickho H
and Delbandi AA: Current and future immunotherapeutic approaches in
pancreatic cancer treatment. J Hematol Oncol. 17:402024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan JQ, Wang MF, Chen HL, Shang D, Das JK
and Song J: Current advances and outlooks in immunotherapy for
pancreatic ductal adenocarcinoma. Mol Cancer. 19:322020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibellini L and Moro L: Programmed cell
death in health and disease. Cells. 10:17652021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tong X, Tang R, Xiao M, Xu J, Wang W,
Zhang B, Liu J, Yu X and Shi S: Targeting cell death pathways for
cancer therapy: Recent developments in necroptosis, pyroptosis,
ferroptosis, and cuproptosis research. J Hematol Oncol. 15:1742022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Fleishman JS, Wang H and Huo L:
Pharmacologically targeting ferroptosis and cuproptosis in
neuroblastoma. Mol Neurobiol. 62:3863–3876. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsang T, Davis CI and Brady DC: Copper
biology. Curr Biol. 31:R421–R427. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Min J and Wang F: Copper
homeostasis and cuproptosis in health and disease. Signal Transduct
Target Ther. 7:3782022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kahlson MA and Dixon SJ: Copper-induced
cell death. Science. 375:1231–1232. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsvetkov P, Coy S, Petrova B, Dreishpoon
M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R,
Spangler RD, et al: Copper induces cell death by targeting
lipoylated TCA cycle proteins. Science. 375:1254–1261. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang D, Chen X and Kroemer G: Cuproptosis:
A copper-triggered modality of mitochondrial cell death. Cell Res.
32:417–418. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun L, Zhang Y, Yang B, Sun S, Zhang P,
Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al: Lactylation of METTL16
promotes cuproptosis via m6A-modification on FDX1 mRNA
in gastric cancer. Nat Commun. 14:65232023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Y, Huo Z, Qi X, Zuo T and Wu Z:
Copper-induced tumor cell death mechanisms and antitumor
theragnostic applications of copper complexes. Nanomedicine (Lond).
17:303–324. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang D, Kroemer G and Kang R: Targeting
cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol.
21:370–388. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu WQ, Lin WR, Yan L, Xu WH and Yang J:
Copper homeostasis and cuproptosis in cancer immunity and therapy.
Immunol Rev. 321:211–227. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie J, Yang Y, Gao Y and He J:
Cuproptosis: Mechanisms and links with cancers. Mol Cancer.
22:462023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tarin M, Babaie M, Eshghi H, Matin MM and
Saljooghi AS: Elesclomol, a copper-transporting therapeutic agent
targeting mitochondria: From discovery to its novel applications. J
Transl Med. 21:7452023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O'Day S, Gonzalez R, Lawson D, Weber R,
Hutchins L, Anderson C, Haddad J, Kong S, Williams A and Jacobson
E: Phase II, randomized, controlled, double-blinded trial of weekly
elesclomol plus paclitaxel versus paclitaxel alone for stage IV
metastatic melanoma. J Clin Oncol. 27:5452–5458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin Y, Liu Y, Xiang X, Long X, Chen Z,
Huang X, Yang J and Li W: Cuproptosis correlates with
immunosuppressive tumor microenvironment based on pan-cancer
multiomics and single-cell sequencing analysis. Mol Cancer.
22:592023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gadiyar V, Lahey KC, Calianese D, Devoe C,
Mehta D, Bono K, Desind S, Davra V and Birge RB: Cell death in the
tumor microenvironment: Implications for cancer immunotherapy.
Cells. 9:22072020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao L, Shay C and Teng Y: Cell death
shapes cancer immunity: Spotlighting PANoptosis. J Exp Clin Cancer
Res. 43:1682024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hänggi K and Ruffell B: Cell death,
therapeutics, and the immune response in cancer. Trends Cancer.
9:381–396. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y,
Sun Y, Zeng F, Chen X and Deng G: Ferroptosis in cancer: From
molecular mechanisms to therapeutic strategies. Signal Transduct
Target Ther. 9:552024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du T, Gao J, Li P, Wang Y, Qi Q, Liu X, Li
J, Wang C and Du L: Pyroptosis, metabolism, and tumor immune
microenvironment. Clin Transl Med. 11:e4922021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han X, Zhang WH, Wang WQ, Yu XJ and Liu L:
Cancer-associated fibroblasts in therapeutic resistance of
pancreatic cancer: Present situation, predicaments, and
perspectives. Biochim Biophys Acta Rev Cancer. 1874:1884442020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Storrs EP, Chati P, Usmani A, Sloan I,
Krasnick BA, Babbra R, Harris PK, Sachs CM, Qaium F, Chatterjee D,
et al: High-dimensional deconstruction of pancreatic cancer
identifies tumor microenvironmental and developmental stemness
features that predict survival. NPJ Precis Oncol. 7:1052023.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang
X, Jin H and Feng L: Ferroptosis inducers enhanced cuproptosis
induced by copper ionophores in primary liver cancer. J Exp Clin
Cancer Res. 42:1422023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reggiardo RE, Maroli SV, Peddu V, Davidson
AE, Hill A, LaMontagne E, Aaraj YA, Jain M, Chan SY and Kim DH:
Profiling of repetitive RNA sequences in the blood plasma of
patients with cancer. Nat Biomed Eng. 7:1627–1635. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song CX, Yin S, Ma L, Wheeler A, Chen Y,
Zhang Y, Liu B, Xiong J, Zhang W, Hu J, et al:
5-Hydroxymethylcytosine signatures in cell-free DNA provide
information about tumor types and stages. Cell Res. 27:1231–1242.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Digre A and Lindskog C: The human protein
atlas-spatial localization of the human proteome in health and
disease. Protein Sci. 30:218–233. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sabah A, Tiun S, Sani NS, Ayob M and Taha
AY: Enhancing web search result clustering model based on multiview
multirepresentation consensus cluster ensemble (mmcc) approach.
PLoS One. 16:e02452642021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Seiler M, Huang CC, Szalma S and Bhanot G:
ConsensusCluster: A software tool for unsupervised cluster
discovery in numerical data. OMICS. 14:109–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC. 14:72013.
|
|
39
|
Wu D, Liu Y, Liu J, Ma L and Tong X:
Myeloid cell differentiation-related gene signature for predicting
clinical outcome, immune microenvironment, and treatment response
in lung adenocarcinoma. Sci Rep. 14:174602024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang L, Wu C, Xu D, Cui Y and Tang J:
Screening of important factors in the early sepsis stage based on
the evaluation of ssGSEA algorithm and ceRNA regulatory network.
Evol Bioinform Online. 17:117693432110584632021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mayakonda A, Lin DC, Assenov Y, Plass C
and Koeffler HP: Maftools: Efficient and comprehensive analysis of
somatic variants in cancer. Genome Res. 28:1747–1756. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Geeleher P, Cox N and Huang RS:
pRRophetic: An R package for prediction of clinical
chemotherapeutic response from tumor gene expression levels. PLoS
One. 9:e1074682014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ringnér M: What is principal component
analysis? Nat Biotechnol. 26:303–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sherman MH and Beatty GL: Tumor
microenvironment in pancreatic cancer pathogenesis and therapeutic
resistance. Annu Rev Pathol. 18:123–148. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moffitt RA, Marayati R, Flate EL, Volmar
KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung
AH, et al: Virtual microdissection identifies distinct tumor- and
stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat
Genet. 47:1168–1178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chakravarthy A, Khan L, Bensler NP, Bose P
and De Carvalho DD: TGF-β-associated extracellular matrix genes
link cancer-associated fibroblasts to immune evasion and
immunotherapy failure. Nat Commun. 9:46922018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Collisson EA, Sadanandam A, Olson P, Gibb
WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, et al:
Subtypes of pancreatic ductal adenocarcinoma and their differing
responses to therapy. Nat Med. 17:500–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Samstein RM, Lee CH, Shoushtari AN,
Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ,
Omuro A, et al: Tumor mutational load predicts survival after
immunotherapy across multiple cancer types. Nat Genet. 51:202–206.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kang K, Xie F, Mao J, Bai Y and Wang X:
Significance of tumor mutation burden in immune infiltration and
prognosis in cutaneous melanoma. Front Oncol. 10:5731412020.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
McNamara MG, Jacobs T, Lamarca A, Hubner
RA, Valle JW and Amir E: Impact of high tumor mutational burden in
solid tumors and challenges for biomarker application. Cancer Treat
Rev. 89:1020842020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hayashi A, Hong J and Iacobuzio-Donahue
CA: The pancreatic cancer genome revisited. Nat Rev Gastroenterol
Hepatol. 18:469–481. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Leng S, Huang W, Chen Y, Yang Y, Feng D,
Liu W, Gao T, Ren Y, Huo M, Zhang J, et al: SIRT1 coordinates with
the CRL4B complex to regulate pancreatic cancer stem cells to
promote tumorigenesis. Cell Death Differ. 28:3329–3343. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Marengo A, Forciniti S, Dando I, Dalla
Pozza E, Stella B, Tsapis N, Yagoubi N, Fanelli G, Fattal E,
Heeschen C, et al: Pancreatic cancer stem cell proliferation is
strongly inhibited by diethyldithiocarbamate-copper complex loaded
into hyaluronic acid decorated liposomes. Biochim Biophys Acta Gen
Subj. 1863:61–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Babak MV and Ahn D: Modulation of
intracellular copper levels as the mechanism of action of
anticancer copper complexes: Clinical relevance. Biomedicines.
9:8522021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Helgadottir H, Ghiorzo P, van Doorn R,
Puig S, Levin M, Kefford R, Lauss M, Queirolo P, Pastorino L,
Kapiteijn E, et al: Efficacy of novel immunotherapy regimens in
patients with metastatic melanoma with germline CDKN2A mutations. J
Med Genet. 57:316–321. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang P, Guo W, Liu S, Li S, Li J, Ding B,
Yin F, Yang Y, Li X, Cao P, et al: Novel simplePt@PCN-Cu-induced
cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal
adenocarcinoma through mitochondrial HK2-mediated PD-L1
upregulation. J Exp Clin Cancer Res. 44:1492025. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gao S, Ge H, Gao L, Gao Y, Tang S, Li Y,
Yuan Z and Chen W: Silk Fibroin nanoparticles for enhanced
cuproptosis and immunotherapy in pancreatic cancer treatment. Adv
Sci (Weinh). 12:e24176762025. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang C, Zeng Y, Guo X, Shen H, Zhang J,
Wang K, Ji M and Huang S: Pan-cancer analyses confirmed the
cuproptosis-related gene FDX1 as an immunotherapy predictor and
prognostic biomarker. Front Genet. 13:9237372022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Costa A, Kieffer Y, Scholer-Dahirel A,
Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L,
Bernard C, et al: Fibroblast heterogeneity and immunosuppressive
environment in human breast cancer. Cancer Cell. 33:463–479.e10.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Huang H, Wang Z, Zhang Y, Pradhan RN,
Ganguly D, Chandra R, Murimwa G, Wright S, Gu X, Maddipati R, et
al: Mesothelial cell-derived antigen-presenting cancer-associated
fibroblasts induce expansion of regulatory T cells in pancreatic
cancer. Cancer Cell. 40:656–673.e7. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Derynck R, Turley SJ and Akhurst RJ: TGFβ
biology in cancer progression and immunotherapy. Nat Rev Clin
Oncol. 18:9–34. 2021. View Article : Google Scholar : PubMed/NCBI
|
